2026. Molecular docking studies FDA approved Quercetin inhibitory potential of ATP synthase F0F1 subunit beta from Streptococcus mutans. MSW Management Journal. 36, 2 (May 2026), 1394–1397. DOI:https://doi.org/10.7492/xadsj448.